Lung Infection: Clinical Trials

3 trials for Lung Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Terminated 1, Withdrawn 1
Phase 22Completed 1, Withdrawn 1

Follow Lung Infection: new trials by email Literature Review of Lung Infection trials Research Report on Lung Infection

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
AP-PA02, Placebo - Cystic Fibrosis, Pseudomonas Aeruginosa
Phase 1 / Phase 2CompletedArmata Pharmaceuticals, Inc.292020-12-222024-01-31
Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen
Opaganib - COVID-19, Lung Infection
Phase 1 / Phase 2WithdrawnRedHill Biopharma Limited2020-08-012020-08-11
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
Inhaled SNSP113, Inhaled Placebo - Lung Diseases, Pulmonary Disease
Phase 1TerminatedSynspira, Inc.322017-09-282018-05-25

Narrower conditions

Cystic Fibrosis (2)  ·  Burkholderia Infections (1)  ·  COVID-19 (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections, Nontuberculous (1)  ·  Pneumonia (1)  ·  Pseudomonas Infections (1)  ·  Respiratory Tract Diseases (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Infant, Newborn, Diseases (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Pancreatic Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Actinomycetales Infections (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)

Interventions

3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (1)

Sponsors

Armata Pharmaceuticals, Inc. (1)  ·  RedHill Biopharma Limited (1)  ·  Synspira, Inc. (1)

Countries

Israel (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Maria Theresa Basco, MD, MPH (1)  ·  Mark L Levitt, MD (1)  ·  Mina Pastagia, MD, MS (1)